Pulmatrix

$1.02
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.04 (+3.76%) As of 5:18 PM UTC today

Why Robinhood?

You can buy or sell Pulmatrix and other stocks, options, and ETFs commission-free!

About PULM

Pulmatrix, Inc. Common Stock, also called Pulmatrix, is a clinical stage biotechnology company, which engages in the discovery and development of novel inhaled therapeutic products for respiratory and other diseases.

CEO
Teofilo Raad
Employees
20
Headquarters
Lexington, Massachusetts
Founded
2015
Market Cap
70.12M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.55M
High Today
$1.05
Low Today
$0.9501
Open Price
$0.96
Volume
984.42K
52 Week High
$3.04
52 Week Low
$0.9095

PULM News

MarketWatchApr 9

Pulmatrix Inc. Stock Quote (U.S.: Nasdaq)

Pulmatrix Inc. Pulmatrix, Inc. is a clinical stage biotechnology company, which engages in the discovery and development of novel inhaled therapeutic products

PULM Earnings

-$0.31
-$0.21
-$0.10
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 13, Pre-Market

You May Also Like

MTZ
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure